{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/parkinsons-disease/management/end-stage-parkinsons-disease/","result":{"pageContext":{"chapter":{"id":"c0adefb6-a71d-5b3c-bc2d-b86a13219e16","slug":"end-stage-parkinsons-disease","fullItemName":"Scenario: End-stage Parkinson's disease","depth":2,"htmlHeader":"<!-- begin field 1094fe62-3319-41b3-b997-5fe3e98a4ebb --><h2>Scenario: End-stage Parkinson's disease</h2><!-- end field 1094fe62-3319-41b3-b997-5fe3e98a4ebb -->","summary":"Covers the management of a person with end-stage Parkinson's disease.","htmlStringContent":"<!-- begin item cda9c305-6c9e-4b07-9991-11c18122a607 --><!-- begin field 4013c713-fae0-4323-91f9-acbc015b85a5 --><p>From age 20 years onwards.</p><!-- end field 4013c713-fae0-4323-91f9-acbc015b85a5 --><!-- end item cda9c305-6c9e-4b07-9991-11c18122a607 -->","topic":{"id":"6cfe5031-c78a-5fcf-8597-8688ef0d3a41","topicId":"ac61656d-8e8b-48b8-bf1d-49f506afadb6","topicName":"Parkinson's disease","slug":"parkinsons-disease","lastRevised":"Last revised in February 2018","chapters":[{"id":"8bebf6b8-3a72-530a-ac48-52a8618f2267","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"044ab1d2-584c-5ed9-ab24-f7c8d64ef959","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"51b4e173-4f8a-5f7a-9e4a-fff68f32b031","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"29a7b8ce-d32b-5e9d-a682-56084e34b727","slug":"changes","fullItemName":"Changes"},{"id":"e1bb005f-8b49-5ae3-9670-a888d5def19a","slug":"update","fullItemName":"Update"}]},{"id":"fbbb2e6c-5309-5aa6-a27f-d6f508b6f994","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"40c62f24-40c5-5619-88aa-963a7de0d17d","slug":"goals","fullItemName":"Goals"},{"id":"2b0ddbc1-3535-545a-8be3-996ce778ee4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a8f322a5-4ac1-50c9-8391-83584bd86b30","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d2a1f92e-43cd-575e-bcbd-7bd0e6792634","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e860c3e6-3288-5ee1-bd77-a6d4aa0c3006","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d3463e24-bbaa-5d3a-aca9-0d6da87a47f3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"644e166b-8434-55a7-859c-6479b609051a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"935e4ed2-12f3-5857-9a26-8a3beaed429c","slug":"definition","fullItemName":"Definition"},{"id":"58a49a4b-fb27-55f3-9afb-3c816842a76a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ce592a68-6b1f-5015-8125-2facfdcc4afe","slug":"prognosis","fullItemName":"Prognosis"},{"id":"8a05334f-9e7a-5662-b166-d86bd3c7546e","slug":"complications","fullItemName":"Complications"}]},{"id":"3951c9c0-49fe-5d17-8d1d-4c42b0b95c3f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e7662ffa-e42d-5bb5-9025-2ba5f6587a6f","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"435dc95c-73c1-5636-953b-feb3d7f82aaf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"196d12bb-51bd-5a0b-872d-c7b60bde431b","fullItemName":"Management","slug":"management","subChapters":[{"id":"38b7e750-e77e-5791-a127-6e5192b69597","slug":"suspected-parkinsons-disease","fullItemName":"Scenario: Suspected Parkinson's disease"},{"id":"fae10e1b-26bc-523c-bc3b-ec45e56860ca","slug":"confirmed-parkinsons-disease","fullItemName":"Scenario: Confirmed Parkinson's disease"},{"id":"c0adefb6-a71d-5b3c-bc2d-b86a13219e16","slug":"end-stage-parkinsons-disease","fullItemName":"Scenario: End-stage Parkinson's disease"}]},{"id":"d811822d-b022-5b69-8514-00e15d349643","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"83038956-9818-52c8-9415-85ab073e43aa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"757d939c-8a84-5a32-847b-38d850b38230","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"17a6cb12-1c93-5aff-bc74-2c2cee2f97ee","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bd851d10-0cce-5204-8b2e-54ae60c5767f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9d232b23-7764-59d5-8026-50fff91a905b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7deed303-b70d-5459-8ca1-d40e9dbf3c88","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1a717fd3-80b2-587f-8d46-3f904380d76a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"196d12bb-51bd-5a0b-872d-c7b60bde431b","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"686825d9-7e69-59d5-b15e-a60ba0be39e6","slug":"when-to-suspect-end-stage-parkinsons-disease","fullItemName":"When to suspect end-stage Parkinson's disease","depth":3,"htmlHeader":"<!-- begin field cdbb8044-a411-497f-b829-f2a3a6c2b31f --><h3>When should I suspect end-stage Parkinson's disease?</h3><!-- end field cdbb8044-a411-497f-b829-f2a3a6c2b31f -->","summary":null,"htmlStringContent":"<!-- begin item 471e8337-b06c-43b5-ab66-c4302642b0c3 --><!-- begin field 2c1d185e-2f7b-40a1-b6a5-2448015510d8 --><ul><li><strong>Suspect the person has end-stage Parkinson's disease with a probable life expectancy of 6–12 months if they have:</strong><ul><li>Severe, progressive worsening <a class=\"topic-reference internal-reference\" href=\"/topics/parkinsons-disease/management/confirmed-parkinsons-disease/#motor-symptoms-complications\">motor symptoms and complications</a>, such as increasing 'off' periods, dyskinesia, mobility problems, and falls.</li><li>Severe, progressive worsening <a class=\"topic-reference internal-reference\" href=\"/topics/parkinsons-disease/management/confirmed-parkinsons-disease/#non-motor-symptoms-complications\">non-motor symptoms and complications</a>, including worsening cognitive function, depression, anxiety, hallucinations and/or delusions.</li><li>Symptoms which show a decreasing response to anti-parkinsonian medication or an increasingly complex regime of anti-parkinsonian medication is needed.</li><li>Declining physical functioning and an increasing need for support; limited self-care; in bed or chair over 50% of the day.</li></ul><ul><li>Repeated unplanned or crisis hospital admissions.</li><li>A low body mass index (BMI) or significant weight loss, for example more than 10% weight loss in the past 6 months.</li><li>Dysphagia leading to recurrent aspiration pneumonia, sepsis, breathlessness, or respiratory failure.</li><li>Speech problems causing progressive difficulty communicating and/or progressive dysphagia.</li><li>Significant co-morbidities.</li></ul></li><li><strong>For people with end-stage Parkinson's disease, the focus is on palliative care to relieve symptoms and improve quality of life.</strong></li></ul><!-- end field 2c1d185e-2f7b-40a1-b6a5-2448015510d8 --><!-- end item 471e8337-b06c-43b5-ab66-c4302642b0c3 -->","subChapters":[{"id":"fc0494b0-c91e-5488-bb5d-5269c085c669","slug":"basis-for-recommendation-0e0","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 060ab268-e06a-486c-a81a-7b3f397ecf4e --><h4>Basis for recommendation</h4><!-- end field 060ab268-e06a-486c-a81a-7b3f397ecf4e -->","summary":null,"htmlStringContent":"<!-- begin item 0e04a8a7-fd85-4f88-b120-cfd2cd9edac0 --><!-- begin field dac133e4-7775-437e-bd9c-adb4b8ea0c49 --><p>The recommendations on when to suspect end-stage Parkinson's disease are largely based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Parkinson's disease in adults: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">NICE, 2017</a>], the Scottish Intercollegiate Guidelines Network (SIGN) clinical guideline <em>Diagnosis and pharmacological management of Parkinson's disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">SIGN, 2010</a>], and the Gold Standards Framework <em>Proactive Indentification Guidance</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">Thomas, 2016</a>].</p><ul><li>The Gold Standards Framework lists a number of general indicators of decline and increasing needs, and also specific features of Parkinson's disease that may suggest a person is nearing the end of life [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">Thomas, 2016</a>].</li></ul><!-- end field dac133e4-7775-437e-bd9c-adb4b8ea0c49 --><!-- end item 0e04a8a7-fd85-4f88-b120-cfd2cd9edac0 -->","subChapters":[]}]},{"id":"7673fb0e-096f-5ad5-8003-e18aa5d10222","slug":"managing-end-stage-parkinsons-disease","fullItemName":"Managing end-stage Parkinson's disease","depth":3,"htmlHeader":"<!-- begin field 6db27b0e-81b3-4091-9f45-dc50b7cf7850 --><h3>Managing end-stage Parkinson's disease</h3><!-- end field 6db27b0e-81b3-4091-9f45-dc50b7cf7850 -->","summary":null,"htmlStringContent":"<!-- begin item 655ec8c9-8db1-46b0-be1a-0f2ef75dead8 --><!-- begin field 19edafa6-7757-4843-840b-2a250a20e2d6 --><p><strong>For people with end-stage Parkinson's disease:</strong></p><ul><li><strong>Liaise with the person's specialist team and Parkinson's disease nurse</strong> to ensure their anti-parkinsonian medication is optimal, and to coordinate support and advice from other members of the multidisciplinary team, such as community nursing, palliative care team, occupational therapy, physiotherapy, dietetics, and adult social care, as needed.</li><li><strong>Ensure continuity of care</strong> wherever possible, for example by having a nominated named GP.</li><li><strong>Offer discussion of end-of-life issues,</strong> such as:<ul><li>The disease process.</li><li>Possible treatments.</li><li>What dying might be like and how symptoms can be managed.</li></ul></li><li><strong>Ensure the person has an</strong> <a class=\"topic-reference internal-reference\" href=\"/topics/parkinsons-disease/management/end-stage-parkinsons-disease/#advance-care-plans\">advance care plan</a> (if they wish) and discuss any <a class=\"topic-reference internal-reference\" href=\"/topics/parkinsons-disease/management/end-stage-parkinsons-disease/#advance-decisions\">advance decisions</a> they have.<ul><li>Opportunities to discuss or review an advance care plan and discuss end-of-life issues can arise when there is a clinical event or deterioration, or when there is a change in social circumstances, such as a move into a care home.</li><li>Offer information about Lasting Power of Attorney for finance and/or health and social care future decisions.</li></ul></li><li><strong>Consider withdrawing non-essential medication,</strong> following specialist advice, if the person's symptoms are no longer responding to anti-parkinsonian medication, or adverse effects are not tolerated.</li><li><strong>Consider withdrawing artificial nutrition support</strong> if it is causing discomfort or distress, or is not felt to be in the person's best interest.</li><li><strong>Offer management for symptoms at the end of life,</strong> such as:<ul><li>Pain — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-cancer-care-pain/\">Palliative cancer care - pain</a>.</li><li>Breathlessness — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-dyspnoea/\">Palliative care - dyspnoea</a>.</li><li>Secretions — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-secretions/\">Palliative care - secretions</a>.</li><li>Constipation — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-constipation/\">Palliative care - constipation</a>.</li><li>Nausea and vomiting — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-nausea-vomiting/\">Palliative care - nausea and vomiting</a>.</li><li>Insomnia — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/insomnia/\">Insomnia</a>.</li><li>Depression and anxiety — for more information, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/management/management-approach/#assessing-managing-psychological-needs\">assessing and managing&nbsp;psychological needs</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a>. For prescribing information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a> and <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>.</li><li>Pressure ulcers — ensure the person is regularly assessed, and any ulcers are treated promptly.</li></ul></li><li><strong>Discuss the option of respite care</strong> to help support the person's carers, if appropriate.</li><li><strong>Consider admission to a hospice,</strong> for example if symptoms are not controlled, or if this is the person's preferred place of care.</li><li>For general information on end-of-life care, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a>.</li></ul><!-- end field 19edafa6-7757-4843-840b-2a250a20e2d6 --><!-- end item 655ec8c9-8db1-46b0-be1a-0f2ef75dead8 -->","subChapters":[{"id":"596a09d0-db7e-52fb-8622-a616f9987de6","slug":"advance-care-plans","fullItemName":"Advance care plans","depth":4,"htmlHeader":"<!-- begin field e3eb4bbc-1881-4b3a-b4db-e834cae6c6d8 --><h4>Advance care plans</h4><!-- end field e3eb4bbc-1881-4b3a-b4db-e834cae6c6d8 -->","summary":null,"htmlStringContent":"<!-- begin item 1b414715-0e85-4c80-8172-8f827fab259b --><!-- begin field 9106ecd5-16c4-48ca-ad50-c41442342fc5 --><ul><li><strong>An advance care plan should address:</strong><ul><li>Anticipatory prescribing of medication to manage end-of-life symptoms.</li><li>Discontinuing inappropriate medication or interventions.</li><li>Needs for psychological and spiritual care.</li><li>Care of the family (before and after the person's death).</li><li>When, who, and how to call for help if there is a crisis, and what the options are for management.</li><li>The person's preferences for the place they wish to be cared for, and whether resuscitation should be attempted if they were to have a life-threatening deterioration. This information should be available to out-of-hours and ambulance services.</li><li>Any expressed views on organ or tissue donation, including the possibility of donating tissue to a brain bank for diagnostic confirmation and research.</li></ul></li><li>An advance care plan should be reviewed and updated as the person's situation or views change.</li><li>For more information on advance care planning, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/management/communication/#important-communication-issues\">important communication issues</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a>.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">DH, 2012</a>]</p><!-- end field 9106ecd5-16c4-48ca-ad50-c41442342fc5 --><!-- end item 1b414715-0e85-4c80-8172-8f827fab259b -->","subChapters":[]},{"id":"2dfb275e-285c-5e6f-b745-4acb2e0af612","slug":"advance-decisions","fullItemName":"Advance decisions","depth":4,"htmlHeader":"<!-- begin field 9661f521-d91e-499a-bf78-f985dfd3558a --><h4>Advance decisions</h4><!-- end field 9661f521-d91e-499a-bf78-f985dfd3558a -->","summary":null,"htmlStringContent":"<!-- begin item cf30af19-b0db-475b-97e6-06aa5f6d17f7 --><!-- begin field a177bfc7-b2f0-44c6-9813-b45778675167 --><ul><li><strong>Healthcare professionals are responsible for finding out if a valid advance decision exists. Advance decisions:</strong><ul><li>Allow the person to specify (before they have lost the capacity to decide) what treatments they would not want and would not consent to (for example, cardiopulmonary resuscitation).</li><li>Cannot demand treatments.</li><li>Must be respected by clinicians.</li><li>Can be withdrawn if the person retains (or regains) capacity.</li><li>Can be made verbally, except for decisions that refuse life-sustaining treatment (such as artificial ventilation), which must be written, signed, and witnessed.</li><li>Cannot refuse basic care, such as the provision of warmth, shelter, hygiene, food, and water. However, clinically-assisted nutrition and hydration (that is given intravenously, subcutaneously, or via a gastrostomy), which are considered in law to be medical treatments, can be refused.</li></ul></li><li><strong>An advance decision to refuse treatment (ADRT) is binding if:</strong><ul><li>The person making the ADRT was at least 18 years of age, and had the necessary mental capacity.</li><li>It specifies treatment to be refused, and the applicable circumstances.</li><li>It has not been withdrawn.</li><li>Nobody has subsequently been given Lasting Power of Attorney to make treatment decisions on the person's behalf.</li><li>The person making the ADRT has not subsequently given reason to believe that they have changed their mind.</li></ul></li><li><strong>The legal framework for advance decisions is provided by the Mental Capacity Act 2005,</strong> which also provides for resolution of disputes and disagreements about advance decisions. For further information, see the British Medical Association's <a href=\"https://www.bma.org.uk/advice/employment/ethics/mental-capacity\" target=\"_blank\" data-hyperlink-id=\"d1a0bf5e-7c7a-4090-aed5-a8f7014c965b\">Mental Capacity toolkit</a>.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">GMC, 2010</a>]</p><!-- end field a177bfc7-b2f0-44c6-9813-b45778675167 --><!-- end item cf30af19-b0db-475b-97e6-06aa5f6d17f7 -->","subChapters":[]},{"id":"a045caeb-94bb-5903-8dee-1bb0fd0372ba","slug":"basis-for-recommendation-798","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e2ad976b-c1a0-4a5d-90df-70cc09f1f05c --><h4>Basis for recommendation</h4><!-- end field e2ad976b-c1a0-4a5d-90df-70cc09f1f05c -->","summary":null,"htmlStringContent":"<!-- begin item 7986abc0-5df2-4ce6-ac7e-6728fc592045 --><!-- begin field d34b4a25-7cee-4dae-8dd6-26e7b4c3b0c6 --><p>The recommendations on how to manage end-stage Parkinson's disease are largely based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Parkinson's disease in adults: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">NICE, 2017</a>], the Scottish Intercollegiate Guidelines Network (SIGN) clinical guideline <em>Diagnosis and pharmacological management of Parkinson's disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">SIGN, 2010</a>], the British Dietetic Association (BDA) publication <em>Best practice guideline for dietitians on the management of Parkinson's</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">British Dietetic Association, 2015</a>], and a palliative care textbook <em>A guide to symptom relief in palliative care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">Regnard, 2010</a>].</p><ul><li>The SIGN guideline states that in the later stages of Parkinson's disease, when non-motor symptoms may predominantly affect the person's quality of life, the withdrawal of some drugs may be appropriate [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">SIGN, 2010</a>].</li><li>In addition, the recommendation about assessing for and managing pressure ulcers is based on expert opinion in the NICE clinical guideline <em>Pressure ulcers: prevention and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parkinsons-disease/references/\">NICE, 2014</a>].</li></ul><!-- end field d34b4a25-7cee-4dae-8dd6-26e7b4c3b0c6 --><!-- end item 7986abc0-5df2-4ce6-ac7e-6728fc592045 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}